Compare ARK Genomic Revolution ETF (ARKG) vs Caesars Entertainment Inc (CZR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Caesars Entertainment Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.21, while Caesars Entertainment Inc trades at $29.86 (market cap $6.08B). Which is the better fit depends on your goals.
| ARKG | CZR | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $30.84 |
52-Week Low | $23.09 | $18.14 |
Market Cap | — | $6.08B |
Enterprise Value | — | $30.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
CZR trades at $29.84, up 0.24% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $31.27. The company reported Q1 2026 EPS of -$0.48, missing expectations, and has a negative net income margin of -4.19%. Recent news highlights the pending acquisition by Fertitta Entertainment and the opening of Caesars Republic Lake Tahoe.
CZR faces headwinds from recent earnings misses and negative profitability, but the acquisition offer and improving cash flow trends provide upside potential. Risks include high debt levels and competitive pressures in the leisure sector. Analyst sentiment is mixed with 33% buy ratings, suggesting cautious optimism amid operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Caesars Entertainment Inc
Caesars Entertainment includes around 50 domestic gaming properties across Las Vegas (50% of 2021 EBITDAR before corporate and digital expenses) and regional (63%) markets. Additionally, the company hosts managed properties and digital assets, the later of which produced material EBITDA losses in 2021. Caesars' U.S. presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the U.S. portion of William Hill (it plans to sell the international operation in 2022), a digital sports betting platform.
Read more on CZR →
